We're reflecting on the many accomplishments of our community in 2024 and inviting you to join us in our mission to accelerate cures for kidney cancer in 2025.

Read on for how you can join our efforts!

We're proud to share our "Year in Review," showcasing the steady progress we've made together in 2024.

From funding groundbreaking research and amplifying patient advocacy to fostering global community engagement, 2024 has been a year of impact and momentum in the fight against kidney cancer.

Check out the highlights, including $285 million secured in Kidney Cancer Research Program (KCRP) federal funding since 2017, two Innovation Discovery Grants awarded, and the success of KCRS24, which united researchers and advocates worldwide.

Thank you for being part of our mission to accelerate cures for kidney cancer!

(Click the infographic to open a high-resolution copy.)

It’s hard to grasp the true impact of advocacy in the moment—what difference can one meeting make? But when you hear directly from researchers describing the life-saving breakthroughs fueled by federal research funding, the picture becomes clear: we are moving the needle.

In collaboration with CancerNetwork, KidneyCAN brings you a series of insightful videos and a podcast featuring leading researchers and oncologists discussing how advocacy has transformed kidney cancer research and care.

From ramping up federal funding to accelerating innovative treatments, this is the story of how our collective voice is driving real change.

Don’t miss this powerful look at the impact of your advocacy efforts!

Last month, we hosted an engaging Town Hall focused on managing common gastrointestinal challenges kidney cancer patients face during treatment. This event featured expert insights from Dr. Rana McKay and oncology nurse practitioner Archana Ajmera, both of UC San Diego.

Highlights included:

• Tips for managing gastrointestinal side effects
• Understanding fad diets and supplements
• Advice for addressing weight loss during treatment

Our interactive Q&A session allowed patients and caregivers to ask questions directly and receive actionable advice.

Missed this Town Hall? You can now watch our recording of the event on our YouTube channel!

Also: be sure to stay tuned for our next event on January30, 2025: “Looking Back, Looking Forward.” Join Dr. Sumanta "Monty" Pal and Dr. Laurence Albiges as they review the year’s biggest breakthroughs and share their expectations for 2025.

Keep an eye on your inbox and www.kidneycan.org for registration details soon!

Ryan Steadman, a 44-year-old father of three boys from Cincinnati, Ohio, embodies resilience and positivity in his journey with kidney cancer.

Meet Ryan Steadman, a 44-year-old kidney cancer patient, father, and advocate. After being diagnosed with stage III clear cell renal cell carcinoma in 2022, Ryan has become a passionate voice for kidney cancer research.

Ryan participates in KidneyCAN’s advocacy efforts and serves as a consumer reviewer for the Kidney Cancer Research Program. His work ensures that patient perspectives are central to research funding decisions.

Ryan’s story highlights the power of advocacy and the importance of community support. Read more about his journey and how you can get involved on our website.

When you give to KidneyCAN, you’re not just making a donation—you’re driving change. Your generosity fuels research that leads to breakthroughs, advocacy that secures critical federal funding, and education that empowers patients, caregivers, and healthcare providers.

Carrie gives in honor of her son, Jeff.

Robert gives because he knows others' gifts made his survival possible.

Every contribution, no matter the size, plays a role in this life-saving work. In this season of giving, let’s come together to support patients and families, advance research, and build a brighter future.

Please donate and make an impact today.

Starting January 1, 2025, significant changes to Medicare Part D will enhance prescription drug coverage, offering substantial benefits to kidney cancer patients. Check out this article to learn what you need to know:

Each year, KidneyCAN heads to Washington D.C. to participate in Advocacy Days, working with partners to amplify the voices of the kidney cancer community on Capitol Hill. This is your chance to meet with members of Congress and their staff, discuss critical issues, and push for increased funding for kidney cancer research.

Mark your calendars for KidneyCAN’s 2025 Advocacy Days:

Spring: March 10–11

Fall: September 22–23

During our most recent fall advocacy days, we had 151 advocates from 42 states participating! Help us keep the momentum going!

Nervous about getting involved? No worries! Our Team Leads can walk you through every step so you can advocate effectively, even if you've never participated before.

Investing in Future Cures:

KidneyCAN Funds Three Scholar-In-Training Awards

We’re proud to announce that KidneyCAN has funded three AACR Scholar-in-Training Awards for 2025, supporting early-career researchers advancing kidney cancer research.

These awards provide financial assistance to attend the AACR Annual Meeting in Chicago, helping young investigators present their groundbreaking work. By investing in research across areas like chromophobe kidney cancer and renal medullary carcinoma, we’re ensuring innovative ideas move closer to cures.

We’re excited to foster the next generation of kidney cancer researchers and accelerate progress toward better outcomes.

Are you following KidneyCAN online? Tag @KidneyCAN

in your #kidneycancer posts!

Did you know?

According to the IKCC's 2022 Global Patient Survey, two-thirds of kidney cancer patients were not told what subtype of kidney cancer they had when they were diagnosed. Stay informed! Find information and help at our Patient Resource Center.

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding and facilitating research collaborations. Much of our work is funded by grassroots donors from all over the United States. We can't do this without your support.

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). KidneyCAN's work is funded entirely through donations and contributions.